Role of inflammation, immunity, and oxidative stress in hypertension: New insights and potential therapeutic targets

Hypertension is regarded as the most prominent risk factor for cardiovascular diseases, which have become a primary cause of death, and recent research has demonstrated that chronic inflammation is involved in the pathogenesis of hypertension. Both innate and adaptive immunity are now known to promo...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Frontiers in immunology Ročník 13; s. 1098725
Hlavní autoři: Zhang, Zenglei, Zhao, Lin, Zhou, Xingyu, Meng, Xu, Zhou, Xianliang
Médium: Journal Article
Jazyk:angličtina
Vydáno: Switzerland Frontiers Media S.A 10.01.2023
Témata:
Adaptive Immunity
Cardiovascular Diseases
cytokines
Humans
hypertension
Hypertension - therapy
immunity
Immunology
Inflammation
Oxidative Stress
cytokines
cardiovascular diseases
immunity
inflammation
hypertension
oxidative stress
ISSN:1664-3224, 1664-3224
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Hypertension is regarded as the most prominent risk factor for cardiovascular diseases, which have become a primary cause of death, and recent research has demonstrated that chronic inflammation is involved in the pathogenesis of hypertension. Both innate and adaptive immunity are now known to promote the elevation of blood pressure by triggering vascular inflammation and microvascular remodeling. For example, as an important part of innate immune system, classically activated macrophages (M1), neutrophils, and dendritic cells contribute to hypertension by secreting inflammatory cy3tokines. In particular, interferon-gamma (IFN-γ) and interleukin-17 (IL-17) produced by activated T lymphocytes contribute to hypertension by inducing oxidative stress injury and endothelial dysfunction. However, the regulatory T cells and alternatively activated macrophages (M2) may have a protective role in hypertension. Although inflammation is related to hypertension, the exact mechanisms are complex and unclear. The present review aims to reveal the roles of inflammation, immunity, and oxidative stress in the initiation and evolution of hypertension. We envisage that the review will strengthen public understanding of the pathophysiological mechanisms of hypertension and may provide new insights and potential therapeutic strategies for hypertension.
AbstractList Hypertension is regarded as the most prominent risk factor for cardiovascular diseases, which have become a primary cause of death, and recent research has demonstrated that chronic inflammation is involved in the pathogenesis of hypertension. Both innate and adaptive immunity are now known to promote the elevation of blood pressure by triggering vascular inflammation and microvascular remodeling. For example, as an important part of innate immune system, classically activated macrophages (M1), neutrophils, and dendritic cells contribute to hypertension by secreting inflammatory cy3tokines. In particular, interferon-gamma (IFN-γ) and interleukin-17 (IL-17) produced by activated T lymphocytes contribute to hypertension by inducing oxidative stress injury and endothelial dysfunction. However, the regulatory T cells and alternatively activated macrophages (M2) may have a protective role in hypertension. Although inflammation is related to hypertension, the exact mechanisms are complex and unclear. The present review aims to reveal the roles of inflammation, immunity, and oxidative stress in the initiation and evolution of hypertension. We envisage that the review will strengthen public understanding of the pathophysiological mechanisms of hypertension and may provide new insights and potential therapeutic strategies for hypertension.
Hypertension is regarded as the most prominent risk factor for cardiovascular diseases, which have become a primary cause of death, and recent research has demonstrated that chronic inflammation is involved in the pathogenesis of hypertension. Both innate and adaptive immunity are now known to promote the elevation of blood pressure by triggering vascular inflammation and microvascular remodeling. For example, as an important part of innate immune system, classically activated macrophages (M1), neutrophils, and dendritic cells contribute to hypertension by secreting inflammatory cy3tokines. In particular, interferon-gamma (IFN-γ) and interleukin-17 (IL-17) produced by activated T lymphocytes contribute to hypertension by inducing oxidative stress injury and endothelial dysfunction. However, the regulatory T cells and alternatively activated macrophages (M2) may have a protective role in hypertension. Although inflammation is related to hypertension, the exact mechanisms are complex and unclear. The present review aims to reveal the roles of inflammation, immunity, and oxidative stress in the initiation and evolution of hypertension. We envisage that the review will strengthen public understanding of the pathophysiological mechanisms of hypertension and may provide new insights and potential therapeutic strategies for hypertension.Hypertension is regarded as the most prominent risk factor for cardiovascular diseases, which have become a primary cause of death, and recent research has demonstrated that chronic inflammation is involved in the pathogenesis of hypertension. Both innate and adaptive immunity are now known to promote the elevation of blood pressure by triggering vascular inflammation and microvascular remodeling. For example, as an important part of innate immune system, classically activated macrophages (M1), neutrophils, and dendritic cells contribute to hypertension by secreting inflammatory cy3tokines. In particular, interferon-gamma (IFN-γ) and interleukin-17 (IL-17) produced by activated T lymphocytes contribute to hypertension by inducing oxidative stress injury and endothelial dysfunction. However, the regulatory T cells and alternatively activated macrophages (M2) may have a protective role in hypertension. Although inflammation is related to hypertension, the exact mechanisms are complex and unclear. The present review aims to reveal the roles of inflammation, immunity, and oxidative stress in the initiation and evolution of hypertension. We envisage that the review will strengthen public understanding of the pathophysiological mechanisms of hypertension and may provide new insights and potential therapeutic strategies for hypertension.
Author Zhou, Xingyu
Zhang, Zenglei
Zhao, Lin
Meng, Xu
Zhou, Xianliang
AuthorAffiliation Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing , China
AuthorAffiliation_xml – name: Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing , China
Author_xml – sequence: 1
  givenname: Zenglei
  surname: Zhang
  fullname: Zhang, Zenglei
– sequence: 2
  givenname: Lin
  surname: Zhao
  fullname: Zhao, Lin
– sequence: 3
  givenname: Xingyu
  surname: Zhou
  fullname: Zhou, Xingyu
– sequence: 4
  givenname: Xu
  surname: Meng
  fullname: Meng, Xu
– sequence: 5
  givenname: Xianliang
  surname: Zhou
  fullname: Zhou, Xianliang
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36703963$$D View this record in MEDLINE/PubMed
BookMark eNp9kstuFDEQRS0URELID7BAXrLIDH67mwUSinhEikBCsLbc7uoZR912Y3sC8_d4HkEJC7yxVXXrXEt1n6OTEAMg9JKSJedN-2bw07RZMsLYkpK20Uw-QWdUKbHgjImTB-9TdJHzLalHtJxz-QydcqUJbxU_Q-VbHAHHAfswjHaabPExXOIdPPiyvcQ29Dj-9n1t3AHOJUHOVYzX2xlSgZCr_i3-Ar9qMfvVuuT9yBxrr3g74rKGZGfYFO9wsWkFJb9ATwc7Zrg43ufox8cP368-L26-frq-en-zcJKLsqCuAymGVtGhcQ1IkLK1qnNtL3inLNEdMNL30PRCWrC9A0foIJx1CohWlJ-j6wO3j_bWzMlPNm1NtN7sCzGtjE31XyMYAZx1iom2hV70je6kFo10GmDQgnayst4dWPOmm6B6hZLs-Aj6uBP82qzinam7oYrtAK-PgBR_biAXM_nsYBxtgLjJhmlNKNWsYVX66qHXX5P7tVVBcxC4FHNOMBjny3511dqPhhKzC4nZh8TsQmKOIamj7J_Re_p_hv4ARc3E_w
CitedBy_id crossref_primary_10_25259_IJCDW_9_2024
crossref_primary_10_3389_fnut_2024_1410154
crossref_primary_10_3390_antiox13080923
crossref_primary_10_1186_s12872_025_05072_1
crossref_primary_10_1097_HJH_0000000000003927
crossref_primary_10_11154_pain_40_12
crossref_primary_10_3389_fcvm_2025_1538095
crossref_primary_10_3390_nu16162580
crossref_primary_10_1186_s12889_025_22764_7
crossref_primary_10_1007_s10719_024_10163_w
crossref_primary_10_1097_FJC_0000000000001649
crossref_primary_10_1093_ajh_hpaf034
crossref_primary_10_2147_JIR_S477554
crossref_primary_10_3389_fphys_2025_1587635
crossref_primary_10_1007_s12035_025_04714_x
crossref_primary_10_1186_s12933_025_02775_9
crossref_primary_10_2174_0115665240294605240426123650
crossref_primary_10_1016_j_saa_2024_124647
crossref_primary_10_3389_fnut_2024_1419379
crossref_primary_10_1016_j_mehy_2024_111553
crossref_primary_10_3390_ncrna10030033
crossref_primary_10_1111_jce_16632
crossref_primary_10_3390_antiox13091034
crossref_primary_10_1016_j_ecoenv_2025_118888
crossref_primary_10_2217_fca_2023_0030
crossref_primary_10_1111_apha_70091
crossref_primary_10_3389_fcvm_2023_1211199
crossref_primary_10_1007_s00210_025_04008_y
crossref_primary_10_1097_MD_0000000000044097
crossref_primary_10_31083_RCM37415
crossref_primary_10_3389_fendo_2023_1173399
crossref_primary_10_4236_health_2024_163015
crossref_primary_10_1186_s12871_025_03011_3
crossref_primary_10_3389_fcvm_2024_1326348
crossref_primary_10_3389_fneur_2024_1428625
crossref_primary_10_1038_s41380_025_03256_x
crossref_primary_10_3390_antiox12061221
crossref_primary_10_3390_nu16132144
crossref_primary_10_1097_MD_0000000000038810
crossref_primary_10_1016_j_bioorg_2025_108940
crossref_primary_10_1097_HJH_0000000000004051
crossref_primary_10_1134_S0022093024050296
crossref_primary_10_3390_diseases13050132
crossref_primary_10_1016_j_apmt_2024_102259
crossref_primary_10_3389_fimmu_2024_1376421
crossref_primary_10_1186_s12872_025_05094_9
crossref_primary_10_20935_AcadMed7492
crossref_primary_10_3389_fnut_2025_1582495
crossref_primary_10_7717_peerj_17638
crossref_primary_10_1038_s41598_024_77689_9
crossref_primary_10_2147_NDT_S525882
crossref_primary_10_2147_JIR_S531346
crossref_primary_10_1080_14712598_2024_2384090
crossref_primary_10_1111_bcpt_70000
crossref_primary_10_1097_HJH_0000000000004085
crossref_primary_10_1155_2024_5324127
crossref_primary_10_1097_MBP_0000000000000766
crossref_primary_10_3390_bios15030161
crossref_primary_10_1111_jch_14829
crossref_primary_10_4103_ejpi_EJPI_D_24_00085
crossref_primary_10_3390_molecules29184425
crossref_primary_10_1038_s41598_024_71754_z
crossref_primary_10_1186_s40001_023_01474_z
crossref_primary_10_3389_fimmu_2023_1279439
crossref_primary_10_3390_ijms26073345
crossref_primary_10_3389_fendo_2024_1379130
crossref_primary_10_1016_j_jep_2023_117121
crossref_primary_10_1134_S1022795424701825
crossref_primary_10_3390_metabo14080452
crossref_primary_10_3389_fimmu_2025_1620585
crossref_primary_10_3390_nu17020241
crossref_primary_10_3390_ijms24119236
crossref_primary_10_1177_11795514231220780
crossref_primary_10_1007_s12011_025_04794_9
crossref_primary_10_1007_s11906_023_01263_3
crossref_primary_10_3390_antiox14070883
crossref_primary_10_1042_CS20240699
crossref_primary_10_3389_fimmu_2025_1501432
crossref_primary_10_1177_03000605251362017
crossref_primary_10_3389_fpubh_2024_1338435
crossref_primary_10_1016_j_msard_2025_106556
crossref_primary_10_3390_toxics13020118
crossref_primary_10_1007_s12012_025_10034_2
crossref_primary_10_1016_j_ecoenv_2025_118611
crossref_primary_10_1186_s12903_024_04708_6
crossref_primary_10_1016_j_jad_2024_08_172
crossref_primary_10_1371_journal_pone_0306137
crossref_primary_10_1007_s11886_023_01931_5
crossref_primary_10_1186_s12959_024_00618_3
crossref_primary_10_1080_10641963_2025_2535328
crossref_primary_10_4274_jtss_galenos_2024_08769
crossref_primary_10_1089_scd_2024_0195
crossref_primary_10_1177_17539447231215213
crossref_primary_10_2147_JIR_S478568
crossref_primary_10_3389_fcvm_2025_1645793
crossref_primary_10_1097_MD_0000000000040631
crossref_primary_10_1016_j_aggp_2025_100140
crossref_primary_10_1002_cam4_70777
crossref_primary_10_3390_toxics13010037
crossref_primary_10_3390_foods14091646
crossref_primary_10_1038_s41598_025_87253_8
crossref_primary_10_3390_md23010047
crossref_primary_10_1016_j_aqrep_2024_102584
crossref_primary_10_3390_ijms24119428
crossref_primary_10_34133_research_0679
crossref_primary_10_1016_j_jep_2024_118932
crossref_primary_10_1161_HYPERTENSIONAHA_124_23580
crossref_primary_10_3390_ijms26125434
crossref_primary_10_3390_biomedicines12071528
crossref_primary_10_1016_j_biopha_2025_118412
crossref_primary_10_1152_ajpheart_00075_2025
crossref_primary_10_1371_journal_pone_0329022
crossref_primary_10_1038_s41598_025_86430_z
crossref_primary_10_1186_s40885_024_00281_w
crossref_primary_10_1371_journal_pone_0329540
crossref_primary_10_1038_s41371_024_00975_6
crossref_primary_10_3390_biology13070519
crossref_primary_10_1021_envhealth_4c00182
crossref_primary_10_1371_journal_pone_0325620
crossref_primary_10_1007_s40520_025_02968_y
crossref_primary_10_3390_biom13050835
crossref_primary_10_3390_ijms26083722
crossref_primary_10_1002_ptr_8335
crossref_primary_10_3390_antiox13060688
crossref_primary_10_1038_s41440_024_01791_8
crossref_primary_10_1155_ijcp_9977641
crossref_primary_10_1097_MD_0000000000043638
crossref_primary_10_3389_fcvm_2025_1621911
crossref_primary_10_1002_iid3_1345
crossref_primary_10_3389_fendo_2024_1429662
crossref_primary_10_3390_medsci13030087
crossref_primary_10_1080_00015385_2025_2554405
crossref_primary_10_3390_molecules28135053
crossref_primary_10_3390_geriatrics10020052
crossref_primary_10_1039_D4FO03181D
crossref_primary_10_3389_fnut_2024_1429191
crossref_primary_10_3389_fimmu_2024_1338745
crossref_primary_10_1016_j_bcp_2024_116480
crossref_primary_10_3390_nu15051204
crossref_primary_10_1080_13803395_2025_2527341
crossref_primary_10_1038_s41598_025_05197_5
crossref_primary_10_1016_j_ejphar_2025_177524
crossref_primary_10_1152_ajprenal_00268_2023
crossref_primary_10_51789_cmsj_2026_6_e1
crossref_primary_10_3390_jcm14082678
crossref_primary_10_1002_jcu_24055
crossref_primary_10_1093_ajh_hpae041
crossref_primary_10_12677_acm_2025_152541
crossref_primary_10_5937_jomb0_46526
crossref_primary_10_3390_ijms252211859
crossref_primary_10_3389_fcvm_2025_1529431
crossref_primary_10_1016_j_gendis_2024_101332
crossref_primary_10_1093_bbb_zbae170
crossref_primary_10_3389_fcvm_2024_1355014
crossref_primary_10_3390_biomedicines13061429
crossref_primary_10_1021_acs_jproteome_4c00701
crossref_primary_10_1038_s41420_024_02278_8
crossref_primary_10_3389_fcvm_2025_1549157
crossref_primary_10_1002_alz_70681
crossref_primary_10_1177_08850666241272068
crossref_primary_10_14814_phy2_16094
crossref_primary_10_3389_fcvm_2024_1335395
crossref_primary_10_3389_fcvm_2024_1529903
crossref_primary_10_1016_j_freeradbiomed_2024_09_048
crossref_primary_10_3389_fphar_2025_1561385
crossref_primary_10_3892_br_2024_1764
crossref_primary_10_3390_biom13071023
crossref_primary_10_1186_s12933_024_02191_5
crossref_primary_10_3389_fimmu_2024_1380493
crossref_primary_10_3390_children12060806
crossref_primary_10_1016_j_eujim_2023_102282
crossref_primary_10_3390_psychiatryint6030104
crossref_primary_10_3390_jcm13020505
crossref_primary_10_1038_s41581_025_00960_3
crossref_primary_10_1007_s12602_024_10235_1
crossref_primary_10_1080_17520363_2025_2542111
crossref_primary_10_52420_umj_24_3_174
Cites_doi 10.1161/01.ATV.20.10.2175
10.1016/j.pharmthera.2013.07.004
10.1161/CIRCRESAHA.116.307709
10.1038/s41590-021-00886-5
10.1146/annurev-physiol-012110-142247
10.1093/eurheartj/ehv544
10.1161/01.HYP.37.2.261
10.1016/j.pharmthera.2021.108053
10.1016/j.ijcard.2015.07.078
10.1016/S0021-9150(00)00674-2
10.1159/000443424
10.1053/j.ackd.2019.03.001
10.1128/MCB.17.10.5719
10.1161/01.HYP.0000138070.47616.9d
10.1016/j.cyto.2018.07.003
10.1161/JAHA.118.008757
10.1016/S2213-8587(14)70102-0
10.1056/NEJMoa1314258
10.25011/cim.v38i6.26202
10.1152/ajplung.00378.2002
10.1038/nature01339
10.1016/j.atherosclerosis.2004.08.020
10.1161/01.RES.86.5.494
10.1007/s11906-020-01091-9
10.3389/fphys.2012.00128
10.1038/s41590-019-0548-1
10.1007/s11906-016-0628-7
10.1161/HYPERTENSIONAHA.119.12604
10.1161/01.HYP.0000039961.13718.00
10.1161/HYPERTENSIONAHA.111.187021
10.1016/j.metabol.2017.06.002
10.1001/jama.290.22.2945
10.1161/HYPERTENSIONAHA.110.158071
10.1152/ajpregu.00207.2009
10.1161/HYPERTENSIONAHA.119.13982
10.1016/j.freeradbiomed.2008.05.009
10.1186/s12933-021-01356-w
10.1152/ajpheart.00708.2005
10.3109/07853890.2011.653393
10.1084/jem.20070657
10.1161/HYPERTENSIONAHA.113.02191
10.1007/s00109-016-1481-5
10.1007/s11906-019-0907-1
10.3389/fimmu.2021.668219
10.1152/physiolgenomics.00136.2014
10.1016/j.bbadis.2021.166241
10.1007/s11906-018-0903-x
10.1152/ajplung.00205.2013
10.1046/j.1523-1755.2003.00762.x
10.1161/CIRCRESAHA.121.320239
10.1161/HYPERTENSIONAHA.116.07237
10.1038/s41419-020-02985-x
10.1161/HYPERTENSIONAHA.112.199265
10.1161/01.ATV.0000181743.28028.57
10.1161/01.ATV.0000065234.70518.26
10.1111/j.1742-7843.2012.00911.x
10.1016/j.phrs.2010.07.003
10.1038/s41577-019-0160-5
10.1155/2019/5018410
10.1007/s10753-021-01467-2
10.1161/HYPERTENSIONAHA.119.13642
10.1161/HYPERTENSIONAHA.121.17955
10.1161/CIRCRESAHA.116.303697
10.1016/j.cmet.2017.06.018
10.1186/s12974-020-1728-5
10.1182/blood-2011-01-330878
10.1161/HYPERTENSIONAHA.109.145094
10.1016/j.lfs.2021.119097
10.1152/physrev.00018.2001
10.1016/j.ajpath.2014.01.032
10.1001/jama.2010.650
10.1038/ni.1703
10.1016/S0140-6736(16)31919-5
10.1007/s11906-011-0224-9
10.1038/nature10759
10.1161/HYPERTENSIONAHA.111.189761
10.1161/CIRCULATIONAHA.109.930446
10.1038/nri1184
10.3390/antiox10101561
10.1161/HYPERTENSIONAHA.115.05315
10.1038/s41569-019-0260-8
10.1016/j.phrs.2019.104451
10.1038/jhh.2013.80
10.1016/j.redox.2019.101330
10.1016/j.pharmthera.2010.05.002
10.1038/nri2691
10.1161/01.ATV.0000243924.00970.cb
10.1046/j.1523-1755.2001.00737.x
10.1083/jcb.106.2.311
10.1097/HJH.0b013e328362feb7
10.1161/HYPERTENSIONAHA.116.08373
10.1158/1078-0432.CCR-16-2071
10.1161/HYPERTENSIONAHA.110.150409
10.1681/ASN.2007020220
10.1111/bph.12876
10.1038/cddis.2017.470
10.1152/ajpheart.01118.2006
10.1161/01.HYP.19.6.804
10.1042/bj3340297
10.1161/HYPERTENSIONAHA.118.10824
10.1038/s41581-019-0110-2
10.1161/CIRCULATIONAHA.111.034470
10.1161/CIRCRESAHA.115.306010
10.1016/j.pharmthera.2020.107799
10.1016/j.jacc.2009.05.066
10.1016/j.micpath.2017.09.041
10.1038/sj.jhh.1001845
10.1074/jbc.M114.604231
10.1161/HYPERTENSIONAHA.112.200337
10.1155/2012/946048
10.1186/1742-2094-9-212
10.3389/fimmu.2019.02025
10.1074/jbc.M110.192138
10.1016/S0140-6736(99)04410-4
10.1161/HYPERTENSIONAHA.114.04975
10.1096/fj.201500088R
10.1038/hr.2010.264
10.1161/HYP.0000000000000066
10.1016/j.cyto.2013.07.022
10.1161/01.CIR.103.6.799
10.1161/hy0302.104670
10.1084/jem.20171773
10.1016/j.phrs.2017.05.020
10.1161/CIRCRESAHA.116.303771
10.1161/HYPERTENSIONAHA.117.07802
10.1161/01.HYP.0000057421.28533.37
10.1038/ni1110-973
10.1186/1423-0127-20-69
10.1172/JCI60113
10.1016/j.cjca.2019.06.021
10.1053/j.ajkd.2006.08.015
10.1161/CIRCRESAHA.121.318061
10.1097/MNH.0b013e3283360a2e
10.1093/cvr/cvaa257
10.1016/j.redox.2019.101295
10.1016/j.neuron.2012.12.023
10.1016/j.cjca.2020.01.013
10.1002/mnfr.201800033
10.1161/01.RES.87.10.840
10.1136/annrheumdis-2020-218272
10.1161/HYPERTENSIONAHA.116.08874
10.1161/hh1101.092677
10.1161/CIRCULATIONAHA.119.045102
10.1016/S0895-7061(97)00088-5
10.1161/HYPERTENSIONAHA.115.05333
10.1038/hr.2010.193
10.1161/01.HYP.0000101687.89160.19
10.1016/S0002-9440(10)64445-8
10.1152/ajpheart.2001.280.2.H528
10.1016/S0022-2143(97)90178-5
10.1056/NEJMoa1315231
10.1172/jci.insight.148668
10.1126/science.abg3067
10.1093/cvr/cvy252
10.1152/ajpheart.00707.2009
10.1681/ASN.2006080918
10.1097/01.mnh.0000203189.57513.76
10.1096/fj.11-195198
10.1093/eurheartj/ehu272
10.1186/s40168-016-0222-x
ContentType Journal Article
Copyright Copyright © 2023 Zhang, Zhao, Zhou, Meng and Zhou.
Copyright © 2023 Zhang, Zhao, Zhou, Meng and Zhou 2023 Zhang, Zhao, Zhou, Meng and Zhou
Copyright_xml – notice: Copyright © 2023 Zhang, Zhao, Zhou, Meng and Zhou.
– notice: Copyright © 2023 Zhang, Zhao, Zhou, Meng and Zhou 2023 Zhang, Zhao, Zhou, Meng and Zhou
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.3389/fimmu.2022.1098725
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1664-3224
ExternalDocumentID oai_doaj_org_article_4e32b62499ed4d87b57485c7eef741b5
PMC9871625
36703963
10_3389_fimmu_2022_1098725
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GrantInformation_xml – fundername: ;
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EBS
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
PGMZT
RNS
RPM
ACXDI
CGR
CUY
CVF
ECM
EIF
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c534t-1cbe54f961f8c8e5e559a6bc9d43b6a07be20dde8d45aeadcec01f4cac6e07613
IEDL.DBID DOA
ISICitedReferencesCount 237
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000917714900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1664-3224
IngestDate Fri Oct 03 12:45:57 EDT 2025
Thu Aug 21 18:38:37 EDT 2025
Fri Sep 05 12:24:10 EDT 2025
Mon Jul 21 06:04:55 EDT 2025
Sat Nov 29 03:32:06 EST 2025
Tue Nov 18 22:44:25 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords cytokines
cardiovascular diseases
immunity
inflammation
hypertension
oxidative stress
Language English
License Copyright © 2023 Zhang, Zhao, Zhou, Meng and Zhou.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c534t-1cbe54f961f8c8e5e559a6bc9d43b6a07be20dde8d45aeadcec01f4cac6e07613
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Reviewed by: Alberto N. Peón, Sociedad Española de Beneficencia, Mexico; Aisah Aniisah Aubdool, Queen Mary University of London, United Kingdom
Edited by: Jianmin Chen, Queen Mary University of London, United Kingdom
These authors have contributed equally to this work
This article was submitted to Inflammation, a section of the journal Frontiers in Immunology
OpenAccessLink https://doaj.org/article/4e32b62499ed4d87b57485c7eef741b5
PMID 36703963
PQID 2770117282
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_4e32b62499ed4d87b57485c7eef741b5
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9871625
proquest_miscellaneous_2770117282
pubmed_primary_36703963
crossref_citationtrail_10_3389_fimmu_2022_1098725
crossref_primary_10_3389_fimmu_2022_1098725
PublicationCentury 2000
PublicationDate 2023-01-10
PublicationDateYYYYMMDD 2023-01-10
PublicationDate_xml – month: 01
  year: 2023
  text: 2023-01-10
  day: 10
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in immunology
PublicationTitleAlternate Front Immunol
PublicationYear 2023
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Savoia (B39) 2006; 15
Zhang (B55) 2021; 44
Próchnicki (B52) 2017; 26
Duffy (B161) 1999; 354
Valensi (B45) 2021; 20
Dalekos (B60) 1997; 129
Schiffrin (B124) 2015; 38
De Ciuceis (B115) 2005; 25
Okuda (B20) 1967; 25
Lu (B5) 2018; 20
Mollnau (B155) 2003; 23
Kamat (B22) 2015; 65
Mikolajczyk (B37) 2016; 30
(B1) 2014; 2
O’Donnell (B18) 2015; 116
Chen (B64) 2016; 94
Satou (B97) 2012; 26
Li (B148) 2021; 269
Oh (B71) 2021; 10
Griendling (B151) 2000; 86
Elijovich (B4) 2020; 22
Santisteban (B106) 2016; 118
Cardenas (B149) 2017; 23
Wang (B25) 2003; 421
Langley (B85) 2014; 371
Usui (B44) 2012; 60
Alfaidi (B146) 2018; 7
Matsubara (B157) 2005; 178
Hetemäki (B113) 2021; 12
Higaki (B72) 2021; 117
Landry (B79) 1997; 151
Foley (B40) 2007; 18
Mease (B86) 2014; 370
Fanouriakis (B140) 2021; 80
Atarashi (B160) 1997; 10
Neumann (B80) 2004; 286
Cui (B108) 2019; 26
Harrison (B117) 2012; 3
Guzik (B50) 2017; 70
Stuveling (B42) 2003; 63
Caillon (B8) 2016; 18
Noll (B46) 1998
Fleming (B87) 2001; 88
Ma (B33) 2017; 69
Ogata (B89) 2012; 2012
Chrysanthopoulou (B119) 2021; 6
Shen (B109) 2015; 66
Li (B110) 2017; 5
Yang (B112) 2015; 65
Wenzel (B152) 2008; 45
Kossmann (B14) 2014; 289
Mell (B111) 2015; 47
Wu (B24) 2012; 9
Xia (B63) 2014; 184
Rizzoni (B10) 2022; 79
Sharma (B67) 2021; 22
Shi (B105) 2010; 56
Kleinbongard (B78) 2010; 127
Muller (B11) 2002; 161
Mikolajczyk (B36) 2021; 223
Yasunari (B38) 2002; 39
Makavos (B143) 2020; 36
Toldo (B65) 2022; 236
Heinrich (B88) 1998; 334
Rodrigo (B130) 2011; 34
Itani (B121) 2016; 68
Ishimitsu (B96) 1992; 19
Li (B90) 2010; 299
Higaki (B118) 2019; 21
Münzel (B156) 2009; 54
Rochette (B133) 2013; 140
Sharma (B70) 2014; 306
Aggarwal (B92) 2003; 3
Franchi (B54) 2009; 10
Zhao (B59) 2020; 17
Xiao (B16) 2015; 117
Li (B43) 2020; 155
Markó (B82) 2012; 60
Wenzel (B116) 2015; 36
Vinh (B23) 2010; 122
Zewinger (B49) 2020; 21
Orecchioni (B66) 2022; 375
Siedlinski (B27) 2020; 141
Block (B162) 2001; 37
Ramseyer (B94) 2012; 59
Brands (B75) 2010; 56
Barbaro (B93) 2019; 73
Moens (B134) 2006; 26
Rodriguez-Iturbe (B12) 2001; 59
Xia (B68) 2016; 41
Balakumar (B136) 2010; 62
Ferro (B142) 2011; 34
Herrera (B141) 2006; 17
Mullan (B163) 2002; 40
McMaster (B21) 2015; 116
Barrows (B7) 2019; 26
Norlander (B9) 2018; 215
Majzunova (B135) 2013; 20
Wang (B61) 2011; 118
Yoshida (B77) 2014; 28
Cai (B132) 2000; 87
Touyz (B131) 2004; 44
Camargo (B35) 2018; 72
Leibowitz (B122) 2011; 13
Drummond (B51) 2019; 19
Zhang (B31) 2020; 17
Dörffel (B62) 2001; 157
Schiffrin (B30) 2012; 59
Garvin (B95) 2011; 73
Wright (B19) 2003; 42
Alonso (B81) 1997; 17
Srivastava (B114) 2017; 112
Egan (B6) 2010; 303
Duffy (B159) 2001; 280
Ferrario (B47) 2017; 125
Vázquez-Oliva (B73) 2005; 19
Madhur (B125) 2010; 55
Zaldivia (B17) 2017; 69
Xiao (B28) 2020; 36
Kassan (B123) 2013; 31
Viel (B127) 2010; 298
Wiig (B15) 2013; 123
Sims (B99) 2010; 10
Lee (B74) 2006; 290
Chen (B150) 2019; 2019
Olivares-Silva (B48) 2021; 1867
Griendling (B137) 2000; 20
Postlethwaite (B103) 1988; 106
Sun (B58) 2017
Takac (B32) 2011; 286
Krishnan (B102) 2014; 171
Urwyler (B104) 2020; 75
Schiffrin (B126) 2010; 19
Gu (B84) 2013; 64
Veiras (B83) 2022; 131
Strowig (B56) 2012; 481
Hornig (B153) 2001; 103
Rudemiller (B120) 2014; 63
Muñoz (B29) 2020; 28
(B2) 2017; 389
Rothman (B147) 2020; 75
Whelton (B3) 2018; 71
Segiet (B91) 2019; 113
Morton (B145) 2015; 36
Krishnan (B98) 2019; 115
Xu (B100) 2019; 10
Dröge (B128) 2002; 82
Qi (B139) 2015; 201
Zepeda (B154) 2012; 111
Sesso (B138) 2003; 290
Dounousi (B41) 2006; 48
Rheinheimer (B57) 2017; 74
Tang (B69) 2019; 15
Ulker (B158) 2003; 41
Bai (B53) 2020; 11
Kettenmann (B107) 2013; 77
Montezano (B129) 2012; 44
Toral (B34) 2018
Wenzel (B26) 2011; 124
Ko (B13) 2007; 292
Dinarello (B101) 2010; 11
Guzik (B76) 2007; 204
Boutouyrie (B144) 2021; 128
References_xml – volume: 20
  year: 2000
  ident: B137
  article-title: Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.20.10.2175
– volume: 140
  year: 2013
  ident: B133
  article-title: Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets
  publication-title: Pharmacol Ther
  doi: 10.1016/j.pharmthera.2013.07.004
– volume: 118
  year: 2016
  ident: B106
  article-title: Brain-Gut-Bone marrow axis: Implications for hypertension and related therapeutics
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.116.307709
– volume: 22
  year: 2021
  ident: B67
  article-title: NLRP3 inflammasome in cancer and metabolic diseases
  publication-title: Nat Immunol
  doi: 10.1038/s41590-021-00886-5
– volume: 73
  year: 2011
  ident: B95
  article-title: Regulation of renal NaCl transport by nitric oxide, endothelin, and ATP: Clinical implications
  publication-title: Annu Rev Physiol
  doi: 10.1146/annurev-physiol-012110-142247
– volume: 36
  year: 2015
  ident: B116
  article-title: Heme oxygenase-1 suppresses a pro-inflammatory phenotype in monocytes and determines endothelial function and arterial hypertension in mice and humans
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehv544
– volume: 37
  year: 2001
  ident: B162
  article-title: Ascorbic acid status and subsequent diastolic and systolic blood pressure
  publication-title: Hypertension
  doi: 10.1161/01.HYP.37.2.261
– volume: 236
  start-page: 108053
  year: 2022
  ident: B65
  article-title: Targeting the NLRP3 inflammasome in cardiovascular diseases
  publication-title: Pharmacol Ther
  doi: 10.1016/j.pharmthera.2021.108053
– volume: 201
  year: 2015
  ident: B139
  article-title: Impact of antibiotics on arterial blood pressure in a patient with resistant hypertension-a case report
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2015.07.078
– volume: 157
  year: 2001
  ident: B62
  article-title: Preactivated monocytes from hypertensive patients as a factor for atherosclerosis
  publication-title: Atherosclerosis
  doi: 10.1016/S0021-9150(00)00674-2
– volume: 41
  year: 2016
  ident: B68
  article-title: Characterization and activation of NLRP3 inflammasomes in the renal medulla in mice
  publication-title: Kidney Blood Press Res
  doi: 10.1159/000443424
– volume: 26
  year: 2019
  ident: B7
  article-title: Inflammation, immunity, and oxidative stress in hypertension-partners in crime
  publication-title: Adv Chronic Kidney Dis
  doi: 10.1053/j.ackd.2019.03.001
– volume: 17
  year: 1997
  ident: B81
  article-title: Endothelial cytosolic proteins bind to the 3’ untranslated region of endothelial nitric oxide synthase mRNA: Regulation by tumor necrosis factor alpha
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.17.10.5719
– volume: 44
  year: 2004
  ident: B131
  article-title: Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: What is the clinical significance
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000138070.47616.9d
– volume: 113
  year: 2019
  ident: B91
  article-title: Tumour necrosis factor and interleukin 10 in blood pressure regulation in spontaneously hypertensive and normotensive rats
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2018.07.003
– volume: 7
  year: 2018
  ident: B146
  article-title: Dietary docosahexaenoic acid reduces oscillatory wall shear stress, atherosclerosis, and hypertension, most likely mediated via an IL-1-Mediated mechanism
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.118.008757
– volume: 2
  year: 2014
  ident: B1
  article-title: Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: A comparative risk assessment
  publication-title: Lancet Diabetes Endocrinol
  doi: 10.1016/S2213-8587(14)70102-0
– volume: 371
  year: 2014
  ident: B85
  article-title: Secukinumab in plaque psoriasis–results of two phase 3 trials
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1314258
– volume: 38
  year: 2015
  ident: B124
  article-title: Mechanisms of remodelling of small arteries, antihypertensive therapy and the immune system in hypertension
  publication-title: Clin Invest Med
  doi: 10.25011/cim.v38i6.26202
– volume: 286
  year: 2004
  ident: B80
  article-title: TNF-alpha induces a decrease in eNOS promoter activity
  publication-title: Am J Physiol Lung Cell Mol Physiol
  doi: 10.1152/ajplung.00378.2002
– volume: 421
  year: 2003
  ident: B25
  article-title: Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation
  publication-title: Nature
  doi: 10.1038/nature01339
– volume: 178
  start-page: 57
  year: 2005
  ident: B157
  article-title: Benidipine, a dihydropyridine-calcium channel blocker, prevents lysophosphatidylcholine-induced injury and reactive oxygen species production in human aortic endothelial cells
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2004.08.020
– volume: 86
  start-page: 494
  year: 2000
  ident: B151
  article-title: NAD(P)H oxidase: Role in cardiovascular biology and disease
  publication-title: Circ Res
  doi: 10.1161/01.RES.86.5.494
– volume: 22
  start-page: 79
  year: 2020
  ident: B4
  article-title: The gut microbiome, inflammation, and salt-sensitive hypertension
  publication-title: Curr Hypertens Rep
  doi: 10.1007/s11906-020-01091-9
– volume: 3
  year: 2012
  ident: B117
  article-title: Vascular inflammatory cells in hypertension
  publication-title: Front Physiol
  doi: 10.3389/fphys.2012.00128
– volume: 21
  start-page: 30
  year: 2020
  ident: B49
  article-title: Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation
  publication-title: Nat Immunol
  doi: 10.1038/s41590-019-0548-1
– volume: 18
  start-page: 21
  year: 2016
  ident: B8
  article-title: Role of inflammation and immunity in hypertension: Recent epidemiological, laboratory, and clinical evidence
  publication-title: Curr Hypertens Rep
  doi: 10.1007/s11906-016-0628-7
– volume: 73
  year: 2019
  ident: B93
  article-title: Markers or makers: Inflammatory cytokines in treatment-resistant hypertension
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.119.12604
– volume: 40
  year: 2002
  ident: B163
  article-title: Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000039961.13718.00
– volume: 59
  year: 2012
  ident: B30
  article-title: Vascular remodeling in hypertension: mechanisms and treatment
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.111.187021
– volume: 74
  start-page: 1
  year: 2017
  ident: B57
  article-title: Current role of the NLRP3 inflammasome on obesity and insulin resistance: A systematic review
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2017.06.002
– volume: 290
  year: 2003
  ident: B138
  article-title: C-reactive protein and the risk of developing hypertension
  publication-title: JAMA
  doi: 10.1001/jama.290.22.2945
– volume: 56
  year: 2010
  ident: B75
  article-title: Interleukin 6 knockout prevents angiotensin II hypertension: Role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.110.158071
– volume: 299
  year: 2010
  ident: B90
  article-title: Interleukin-6 stimulates epithelial sodium channels in mouse cortical collecting duct cells
  publication-title: Am J Physiol Regul Integr Comp Physiol
  doi: 10.1152/ajpregu.00207.2009
– volume: 75
  year: 2020
  ident: B104
  article-title: IL (Interleukin)-1 receptor antagonist increases ang (Angiotensin [1-7]) and decreases blood pressure in obese individuals
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.119.13982
– volume: 45
  year: 2008
  ident: B152
  article-title: AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2008.05.009
– volume: 20
  start-page: 170
  year: 2021
  ident: B45
  article-title: Autonomic nervous system activity changes in patients with hypertension and overweight: Role and therapeutic implications
  publication-title: Cardiovasc Diabetol
  doi: 10.1186/s12933-021-01356-w
– volume: 290
  year: 2006
  ident: B74
  article-title: Angiotensin II hypertension is attenuated in interleukin-6 knockout mice
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.00708.2005
– volume: 44
  start-page: S2
  year: 2012
  ident: B129
  article-title: Oxidative stress, noxs, and hypertension: Experimental evidence and clinical controversies
  publication-title: Ann Med
  doi: 10.3109/07853890.2011.653393
– volume: 204
  year: 2007
  ident: B76
  article-title: Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction
  publication-title: J Exp Med
  doi: 10.1084/jem.20070657
– volume: 63
  year: 2014
  ident: B120
  article-title: CD247 modulates blood pressure by altering T-lymphocyte infiltration in the kidney
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.113.02191
– volume: 151
  year: 1997
  ident: B79
  article-title: Activation of the NF-kappa b and I kappa b system in smooth muscle cells after rat arterial injury. induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1
  publication-title: Am J Pathol
– volume: 94
  year: 2016
  ident: B64
  article-title: Contribution of redox-dependent activation of endothelial Nlrp3 inflammasomes to hyperglycemia-induced endothelial dysfunction
  publication-title: J M ol Med (Berl)
  doi: 10.1007/s00109-016-1481-5
– volume: 21
  start-page: 4
  year: 2019
  ident: B118
  article-title: Innate and innate-like immune system in hypertension and vascular injury
  publication-title: Curr Hypertens Rep
  doi: 10.1007/s11906-019-0907-1
– volume: 12
  year: 2021
  ident: B113
  article-title: Fecal bacteria implicated in biofilm production are enriched and associate to gastrointestinal symptoms in patients with APECED - a pilot study
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.668219
– volume: 47
  year: 2015
  ident: B111
  article-title: Evidence for a link between gut microbiota and hypertension in the dahl rat
  publication-title: Physiol Genomics
  doi: 10.1152/physiolgenomics.00136.2014
– volume: 1867
  start-page: 166241
  year: 2021
  ident: B48
  article-title: Resolvin-D1 attenuation of angiotensin II-induced cardiac inflammation in mice is associated with prevention of cardiac remodeling and hypertension
  publication-title: Biochim Biophys Acta Mol Basis Dis
  doi: 10.1016/j.bbadis.2021.166241
– volume: 20
  start-page: 103
  year: 2018
  ident: B5
  article-title: Inflammation in salt-sensitive hypertension and renal damage
  publication-title: Curr Hypertens Rep
  doi: 10.1007/s11906-018-0903-x
– volume: 306
  year: 2014
  ident: B70
  article-title: NADPH oxidase mediates synergistic effects of IL-17 and TNF-alpha on CXCL1 expression by epithelial cells after lung ischemia-reperfusion
  publication-title: Am J Physiol Lung Cell Mol Physiol
  doi: 10.1152/ajplung.00205.2013
– volume: 63
  year: 2003
  ident: B42
  article-title: C-reactive protein is associated with renal function abnormalities in a non-diabetic population
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.2003.00762.x
– volume: 131
  start-page: 59
  year: 2022
  ident: B83
  article-title: Tubular IL-1β induces salt sensitivity in diabetes by activating renal macrophages
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.121.320239
– volume: 68
  year: 2016
  ident: B121
  article-title: Activation of human T cells in hypertension: Studies of humanized mice and hypertensive humans
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.116.07237
– volume: 11
  start-page: 776
  year: 2020
  ident: B53
  article-title: NLRP3 inflammasome in endothelial dysfunction
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-020-02985-x
– volume: 60
  year: 2012
  ident: B82
  article-title: Interferon-γ signaling inhibition ameliorates angiotensin II-induced cardiac damage
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.112.199265
– volume: 25
  year: 2005
  ident: B115
  article-title: Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: Evidence for a role in inflammation in angiotensin-induced vascular injury
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.0000181743.28028.57
– volume: 23
  year: 2003
  ident: B155
  article-title: Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.0000065234.70518.26
– volume: 111
  year: 2012
  ident: B154
  article-title: Effect of carvedilol and nebivolol on oxidative stress-related parameters and endothelial function in patients with essential hypertension
  publication-title: Basic Clin Pharmacol Toxicol
  doi: 10.1111/j.1742-7843.2012.00911.x
– volume: 62
  year: 2010
  ident: B136
  article-title: Multifarious molecular signaling cascades of cardiac hypertrophy: Can the muddy waters be cleared
  publication-title: Pharmacol Res
  doi: 10.1016/j.phrs.2010.07.003
– volume: 19
  year: 2019
  ident: B51
  article-title: Immune mechanisms of hypertension
  publication-title: Nat Rev Immunol
  doi: 10.1038/s41577-019-0160-5
– volume: 2019
  start-page: 5018410
  year: 2019
  ident: B150
  article-title: BCL6 attenuates proliferation and oxidative stress of vascular smooth muscle cells in hypertension
  publication-title: Oxid Med Cell Longev
  doi: 10.1155/2019/5018410
– year: 1998
  ident: B46
  article-title: Role of sympathetic nervous system in hypertension and effects of cardiovascular drugs
  publication-title: Eur Heart J
– volume: 44
  year: 2021
  ident: B55
  article-title: New insights and novel therapeutic potentials for macrophages in myocardial infarction
  publication-title: Inflammation
  doi: 10.1007/s10753-021-01467-2
– volume: 75
  year: 2020
  ident: B147
  article-title: Effects of interleukin-1β inhibition on blood pressure, incident hypertension, and residual inflammatory risk: A secondary analysis of CANTOS
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.119.13642
– volume: 79
  start-page: 691
  year: 2022
  ident: B10
  article-title: Immune system and microvascular remodeling in humans
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.121.17955
– volume: 116
  year: 2015
  ident: B21
  article-title: Inflammation, immunity, and hypertensive end-organ damage
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.116.303697
– volume: 26
  start-page: 71
  year: 2017
  ident: B52
  article-title: Inflammasomes on the crossroads of innate immune recognition and metabolic control
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2017.06.018
– volume: 17
  start-page: 64
  year: 2020
  ident: B59
  article-title: A novel role of NLRP3-generated IL-1β in the acute-chronic transition of peripheral lipopolysaccharide-elicited neuroinflammation: Implications for sepsis-associated neurodegeneration
  publication-title: J Neuroinflamm
  doi: 10.1186/s12974-020-1728-5
– volume: 118
  year: 2011
  ident: B61
  article-title: Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner
  publication-title: Blood
  doi: 10.1182/blood-2011-01-330878
– volume: 55
  year: 2010
  ident: B125
  article-title: Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.109.145094
– volume: 269
  start-page: 119097
  year: 2021
  ident: B148
  article-title: Exercise and food supplement of vitamin c ameliorate hypertension through improvement of gut microflora in the spontaneously hypertensive rats
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2021.119097
– volume: 82
  start-page: 47
  year: 2002
  ident: B128
  article-title: Free radicals in the physiological control of cell function
  publication-title: Physiol Rev
  doi: 10.1152/physrev.00018.2001
– volume: 184
  year: 2014
  ident: B63
  article-title: Endothelial NLRP3 inflammasome activation and enhanced neointima formation in mice by adipokine visfatin
  publication-title: Am J Pathol
  doi: 10.1016/j.ajpath.2014.01.032
– volume: 303
  year: 2010
  ident: B6
  article-title: US Trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008
  publication-title: JAMA
  doi: 10.1001/jama.2010.650
– volume: 10
  year: 2009
  ident: B54
  article-title: The inflammasome: A caspase-1-activation platform that regulates immune responses and disease pathogenesis
  publication-title: Nat Immunol
  doi: 10.1038/ni.1703
– volume: 389
  start-page: 37
  year: 2017
  ident: B2
  article-title: Worldwide trends in blood pressure from 1975 to 2015: A pooled analysis of 1479 population-based measurement studies with 19·1 million participants
  publication-title: Lancet
  doi: 10.1016/S0140-6736(16)31919-5
– volume: 13
  year: 2011
  ident: B122
  article-title: Immune mechanisms in hypertension
  publication-title: Curr Hypertens Rep
  doi: 10.1007/s11906-011-0224-9
– volume: 481
  year: 2012
  ident: B56
  article-title: Inflammasomes in health and disease
  publication-title: Nature
  doi: 10.1038/nature10759
– volume: 59
  year: 2012
  ident: B94
  article-title: Tumor necrosis factor alpha decreases nitric oxide synthase type 3 expression primarily via Rho/Rho kinase in the thick ascending limb
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.111.189761
– volume: 122
  year: 2010
  ident: B23
  article-title: Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.109.930446
– volume: 3
  year: 2003
  ident: B92
  article-title: Signalling pathways of the TNF superfamily: A double-edged sword
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri1184
– volume: 10
  start-page: 1561
  year: 2021
  ident: B71
  article-title: Dieckol reduces muscle atrophy by modulating angiotensin type II type 1 receptor and NADPH oxidase in spontaneously hypertensive rats
  publication-title: Antioxid (Basel)
  doi: 10.3390/antiox10101561
– volume: 65
  year: 2015
  ident: B112
  article-title: Gut dysbiosis is linked to hypertension
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.115.05315
– volume: 17
  year: 2020
  ident: B31
  article-title: NADPH oxidases and oxidase crosstalk in cardiovascular diseases: Novel therapeutic targets
  publication-title: Nat Rev Cardiol
  doi: 10.1038/s41569-019-0260-8
– volume: 155
  start-page: 104451
  year: 2020
  ident: B43
  article-title: Microglia, autonomic nervous system, immunity and hypertension: Is there a link
  publication-title: Pharmacol Res
  doi: 10.1016/j.phrs.2019.104451
– volume: 28
  year: 2014
  ident: B77
  article-title: Infliximab, a TNF-α inhibitor, reduces 24-h ambulatory blood pressure in rheumatoid arthritis patients
  publication-title: J Hum Hypertens
  doi: 10.1038/jhh.2013.80
– volume: 28
  start-page: 101330
  year: 2020
  ident: B29
  article-title: Differential contribution of Nox1, Nox2 and Nox4 to kidney vascular oxidative stress and endothelial dysfunction in obesity
  publication-title: Redox Biol
  doi: 10.1016/j.redox.2019.101330
– volume: 127
  start-page: 295
  year: 2010
  ident: B78
  article-title: TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure
  publication-title: Pharmacol Ther
  doi: 10.1016/j.pharmthera.2010.05.002
– volume: 10
  start-page: 89
  year: 2010
  ident: B99
  article-title: The IL-1 family: Regulators of immunity
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri2691
– volume: 26
  year: 2006
  ident: B134
  article-title: Tetrahydrobiopterin and cardiovascular disease
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.0000243924.00970.cb
– volume: 59
  year: 2001
  ident: B12
  article-title: Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.2001.00737.x
– volume: 25
  year: 1967
  ident: B20
  article-title: Passive transfer of autoimmune induced hypertension in the rat by lymph node cells
  publication-title: Texas Rep Biol Med
– volume: 106
  year: 1988
  ident: B103
  article-title: Modulation of fibroblast functions by interleukin 1: Increased steady-state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1 alpha and beta
  publication-title: J Cell Biol
  doi: 10.1083/jcb.106.2.311
– volume: 31
  year: 2013
  ident: B123
  article-title: CD4+CD25+Foxp3 regulatory T cells and vascular dysfunction in hypertension
  publication-title: J Hypertens
  doi: 10.1097/HJH.0b013e328362feb7
– volume: 69
  year: 2017
  ident: B17
  article-title: Renal denervation reduces monocyte activation and monocyte-platelet aggregate formation: An anti-inflammatory effect relevant for cardiovascular risk
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.116.08373
– volume: 23
  year: 2017
  ident: B149
  article-title: The expanding role of the BCL6 oncoprotein as a cancer therapeutic target
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-16-2071
– volume: 56
  start-page: 297
  year: 2010
  ident: B105
  article-title: Brain microglial cytokines in neurogenic hypertension
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.110.150409
– volume: 18
  year: 2007
  ident: B40
  article-title: End-stage renal disease in the united states: An update from the united states renal data system
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2007020220
– volume: 171
  year: 2014
  ident: B102
  article-title: IL-1β and IL-18: Inflammatory markers or mediators of hypertension
  publication-title: Br J Pharmacol
  doi: 10.1111/bph.12876
– year: 2017
  ident: B58
  article-title: NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2017.470
– volume: 292
  year: 2007
  ident: B13
  article-title: Resistance artery remodeling in deoxycorticosterone acetate-salt hypertension is dependent on vascular inflammation: Evidence from m-CSF-deficient mice
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.01118.2006
– volume: 19
  year: 1992
  ident: B96
  article-title: Interferon gamma attenuates hypertensive renal injury in salt-sensitive Dahl rats
  publication-title: Hypertension
  doi: 10.1161/01.HYP.19.6.804
– volume: 334
  start-page: 297
  year: 1998
  ident: B88
  article-title: Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
  publication-title: Biochem J
  doi: 10.1042/bj3340297
– volume: 72
  year: 2018
  ident: B35
  article-title: Vascular nox (NADPH oxidase) compartmentalization, protein hyperoxidation, and endoplasmic reticulum stress response in hypertension
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.118.10824
– volume: 15
  year: 2019
  ident: B69
  article-title: Macrophages: Versatile players in renal inflammation and fibrosis
  publication-title: Nat Rev Nephrol
  doi: 10.1038/s41581-019-0110-2
– volume: 124
  year: 2011
  ident: B26
  article-title: Lysozyme m-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.111.034470
– volume: 117
  year: 2015
  ident: B16
  article-title: Renal denervation prevents immune cell activation and renal inflammation in angiotensin II-induced hypertension
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.115.306010
– volume: 223
  start-page: 107799
  year: 2021
  ident: B36
  article-title: Role of inflammatory chemokines in hypertension
  publication-title: Pharmacol Ther
  doi: 10.1016/j.pharmthera.2020.107799
– volume: 54
  year: 2009
  ident: B156
  article-title: Nebivolol: The somewhat-different beta-adrenergic receptor blocker
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2009.05.066
– volume: 112
  start-page: 5
  year: 2017
  ident: B114
  article-title: Gut biofilm forming bacteria in inflammatory bowel disease
  publication-title: Microb Pathog
  doi: 10.1016/j.micpath.2017.09.041
– volume: 19
  year: 2005
  ident: B73
  article-title: Lowering of blood pressure leads to decreased circulating interleukin-6 in hypertensive subjects
  publication-title: J Hum Hypertens
  doi: 10.1038/sj.jhh.1001845
– volume: 289
  year: 2014
  ident: B14
  article-title: Inflammatory monocytes determine endothelial nitric-oxide synthase uncoupling and nitro-oxidative stress induced by angiotensin II
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M114.604231
– volume: 60
  year: 2012
  ident: B44
  article-title: Death-associated protein kinase 3 mediates vascular inflammation and development of hypertension in spontaneously hypertensive rats
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.112.200337
– volume: 2012
  start-page: 946048
  year: 2012
  ident: B89
  article-title: Tocilizumab for the treatment of rheumatoid arthritis and other systemic autoimmune diseases: Current perspectives and future directions
  publication-title: Int J Rheumatol
  doi: 10.1155/2012/946048
– volume: 9
  start-page: 212
  year: 2012
  ident: B24
  article-title: Neuroinflammation and oxidative stress in rostral ventrolateral medulla contribute to neurogenic hypertension induced by systemic inflammation
  publication-title: J Neuroinflamm
  doi: 10.1186/1742-2094-9-212
– volume: 10
  year: 2019
  ident: B100
  article-title: The roles of IL-1 family cytokines in the pathogenesis of systemic sclerosis
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2019.02025
– volume: 286
  year: 2011
  ident: B32
  article-title: The e-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.192138
– volume: 354
  year: 1999
  ident: B161
  article-title: Treatment of hypertension with ascorbic acid
  publication-title: Lancet
  doi: 10.1016/S0140-6736(99)04410-4
– volume: 65
  year: 2015
  ident: B22
  article-title: Renal transporter activation during angiotensin-II hypertension is blunted in interferon-γ-/- and interleukin-17A-/- mice
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.114.04975
– volume: 30
  year: 2016
  ident: B37
  article-title: Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension
  publication-title: FASEB J
  doi: 10.1096/fj.201500088R
– volume: 34
  year: 2011
  ident: B130
  article-title: The role of oxidative stress in the pathophysiology of hypertension
  publication-title: Hypertens Res
  doi: 10.1038/hr.2010.264
– volume: 71
  year: 2018
  ident: B3
  article-title: 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: Executive summary: A report of the American college of Cardiology/American heart association task force on clinical practice guidelines
  publication-title: Hypertension
  doi: 10.1161/HYP.0000000000000066
– volume: 64
  year: 2013
  ident: B84
  article-title: IL-17 family: Cytokines, receptors and signaling
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2013.07.022
– volume: 103
  start-page: 799
  year: 2001
  ident: B153
  article-title: Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: Role of superoxide dismutase
  publication-title: Circulation
  doi: 10.1161/01.CIR.103.6.799
– volume: 39
  year: 2002
  ident: B38
  article-title: Oxidative stress in leukocytes is a possible link between blood pressure, blood glucose, and c-reacting protein
  publication-title: Hypertension
  doi: 10.1161/hy0302.104670
– volume: 215
  start-page: 21
  year: 2018
  ident: B9
  article-title: The immunology of hypertension
  publication-title: J Exp Med
  doi: 10.1084/jem.20171773
– volume: 125
  start-page: 57
  year: 2017
  ident: B47
  article-title: Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease
  publication-title: Pharmacol Res
  doi: 10.1016/j.phrs.2017.05.020
– volume: 116
  year: 2015
  ident: B18
  article-title: Sodium intake and cardiovascular health
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.116.303771
– volume: 70
  year: 2017
  ident: B50
  article-title: Oxidative stress, inflammation, and vascular aging in hypertension
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.117.07802
– volume: 41
  year: 2003
  ident: B158
  article-title: Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000057421.28533.37
– volume: 11
  start-page: 973
  year: 2010
  ident: B101
  article-title: IL-1 family nomenclature
  publication-title: Nat Immunol
  doi: 10.1038/ni1110-973
– volume: 20
  start-page: 69
  year: 2013
  ident: B135
  article-title: Redox signaling in pathophysiology of hypertension
  publication-title: J BioMed Sci
  doi: 10.1186/1423-0127-20-69
– volume: 123
  year: 2013
  ident: B15
  article-title: Immune cells control skin lymphatic electrolyte homeostasis and blood pressure
  publication-title: J Clin Invest
  doi: 10.1172/JCI60113
– volume: 36
  year: 2020
  ident: B143
  article-title: Effects of interleukin 17A inhibition on myocardial deformation and vascular function in psoriasis
  publication-title: Can J Cardiol
  doi: 10.1016/j.cjca.2019.06.021
– volume: 48
  year: 2006
  ident: B41
  article-title: Oxidative stress is progressively enhanced with advancing stages of CKD
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2006.08.015
– volume: 128
  year: 2021
  ident: B144
  article-title: Arterial stiffness and cardiovascular risk in hypertension
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.121.318061
– volume: 19
  year: 2010
  ident: B126
  article-title: T Lymphocytes: A role in hypertension
  publication-title: Curr Opin Nephrol Hypertens
  doi: 10.1097/MNH.0b013e3283360a2e
– volume: 117
  year: 2021
  ident: B72
  article-title: Role of interleukin-23/interleukin-17 axis in T-cell-mediated actions in hypertension
  publication-title: Cardiovasc Res
  doi: 10.1093/cvr/cvaa257
– volume: 26
  start-page: 101295
  year: 2019
  ident: B108
  article-title: Vitamin d receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: Role of renin-angiotensin system
  publication-title: Redox Biol
  doi: 10.1016/j.redox.2019.101295
– volume: 77
  year: 2013
  ident: B107
  article-title: Microglia: New roles for the synaptic stripper
  publication-title: Neuron
  doi: 10.1016/j.neuron.2012.12.023
– volume: 36
  year: 2020
  ident: B28
  article-title: Inflammation in hypertension
  publication-title: Can J Cardiol
  doi: 10.1016/j.cjca.2020.01.013
– year: 2018
  ident: B34
  article-title: Lactobacillus fermentum improves tacrolimus-induced hypertension by restoring vascular redox state and improving eNOS coupling
  publication-title: Mol Nutr Food Res
  doi: 10.1002/mnfr.201800033
– volume: 87
  year: 2000
  ident: B132
  article-title: Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress
  publication-title: Circ Res
  doi: 10.1161/01.RES.87.10.840
– volume: 80
  start-page: 14
  year: 2021
  ident: B140
  article-title: Update on the diagnosis and management of systemic lupus erythematosus
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2020-218272
– volume: 69
  start-page: 892
  year: 2017
  ident: B33
  article-title: TMEM16A contributes to endothelial dysfunction by facilitating Nox2 NADPH oxidase-derived reactive oxygen species generation in hypertension
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.116.08874
– volume: 88
  year: 2001
  ident: B87
  article-title: Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity
  publication-title: Circ Res
  doi: 10.1161/hh1101.092677
– volume: 141
  year: 2020
  ident: B27
  article-title: White blood cells and blood pressure: A mendelian randomization study
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.119.045102
– volume: 10
  year: 1997
  ident: B160
  article-title: Vitamin e ameliorates the renal injury of Dahl salt-sensitive rats
  publication-title: Am J Hypertens
  doi: 10.1016/S0895-7061(97)00088-5
– volume: 66
  year: 2015
  ident: B109
  article-title: Microglia participate in neurogenic regulation of hypertension
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.115.05333
– volume: 34
  year: 2011
  ident: B142
  article-title: Does immunosuppressant medication lower blood pressure and arterial stiffness in patients with chronic kidney disease? An observational study
  publication-title: Hypertens Res
  doi: 10.1038/hr.2010.193
– volume: 42
  year: 2003
  ident: B19
  article-title: Determinants of salt sensitivity in black and white normotensive and hypertensive women
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000101687.89160.19
– volume: 161
  year: 2002
  ident: B11
  article-title: Immunosuppressive treatment protects against angiotensin II-induced renal damage
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)64445-8
– volume: 280
  year: 2001
  ident: B159
  article-title: Effect of ascorbic acid treatment on conduit vessel endothelial dysfunction in patients with hypertension
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.2001.280.2.H528
– volume: 129
  year: 1997
  ident: B60
  article-title: Increased serum levels of interleukin-1beta in the systemic circulation of patients with essential hypertension: Additional risk factor for atherogenesis in hypertensive patients
  publication-title: J Lab Clin Med
  doi: 10.1016/S0022-2143(97)90178-5
– volume: 370
  year: 2014
  ident: B86
  article-title: Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1315231
– volume: 6
  start-page: e148668
  year: 2021
  ident: B119
  article-title: Angiotensin II triggers release of neutrophil extracellular traps, linking thromboinflammation with essential hypertension
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.148668
– volume: 375
  year: 2022
  ident: B66
  article-title: Olfactory receptor 2 in vascular macrophages drives atherosclerosis by NLRP3-dependent IL-1 production
  publication-title: Science
  doi: 10.1126/science.abg3067
– volume: 115
  year: 2019
  ident: B98
  article-title: Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension
  publication-title: Cardiovasc Res
  doi: 10.1093/cvr/cvy252
– volume: 298
  year: 2010
  ident: B127
  article-title: Immune regulation and vascular inflammation in genetic hypertension
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.00707.2009
– volume: 17
  year: 2006
  ident: B141
  article-title: Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2006080918
– volume: 15
  year: 2006
  ident: B39
  article-title: Inflammation in hypertension
  publication-title: Curr Opin Nephrol Hypertens
  doi: 10.1097/01.mnh.0000203189.57513.76
– volume: 26
  year: 2012
  ident: B97
  article-title: Interferon-γ biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells
  publication-title: FASEB J
  doi: 10.1096/fj.11-195198
– volume: 36
  year: 2015
  ident: B145
  article-title: The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: The MRC-ILA heart study
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehu272
– volume: 5
  start-page: 14
  year: 2017
  ident: B110
  article-title: Gut microbiota dysbiosis contributes to the development of hypertension
  publication-title: Microbiome
  doi: 10.1186/s40168-016-0222-x
SSID ssj0000493335
Score 2.6755087
SecondaryResourceType review_article
Snippet Hypertension is regarded as the most prominent risk factor for cardiovascular diseases, which have become a primary cause of death, and recent research has...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1098725
SubjectTerms Adaptive Immunity
Cardiovascular Diseases
cytokines
Humans
hypertension
Hypertension - therapy
immunity
Immunology
Inflammation
Oxidative Stress
Title Role of inflammation, immunity, and oxidative stress in hypertension: New insights and potential therapeutic targets
URI https://www.ncbi.nlm.nih.gov/pubmed/36703963
https://www.proquest.com/docview/2770117282
https://pubmed.ncbi.nlm.nih.gov/PMC9871625
https://doaj.org/article/4e32b62499ed4d87b57485c7eef741b5
Volume 13
WOSCitedRecordID wos000917714900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1664-3224
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000493335
  issn: 1664-3224
  databaseCode: DOA
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1664-3224
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000493335
  issn: 1664-3224
  databaseCode: M~E
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagAokLorwaoJWRuNGom9iObW5QteJChRBIe4v8ihrUJtUmi-iF386Mna6yCJULlxwcW7E8Y8988cw3hLxxXGph8MofnIGcg4OcW8ddHsD2hMZwVhkbi03IszO1XOrPs1JfGBOW6IHTwh3xwEpbAUjQwXOvpBWSK-FkCA0YQxvZS8HrmYGp78nvZYyJlCUDKEwfNe3l5RrwYFkig5KSWBt7ZokiYf_fvMw_gyVn1uf0EXk4uY30fZruLrkTusfkfiokef2EjF_6i0D7hoK-gIhTOuIhbWPyx3h9SE3naf-z9ZHmm6YEEehMzwGGrmIQe9-9o3DiQeOAeH2IQ676EaOJ4MuzPC2aoseHp-Tb6cnX44_5VE8hd4LxMS-cDYI3uioa5VQQAdCEqazTnjNbmYW0oVzAcac8FwY0zAW3KBrujKsC_u5gz8hO13dhj1DJtJeFR_JBzzGEotGlt4xxoTS3kmekuFnb2k1k41jz4qIG0IHyqKM8apRHPckjI283Y64S1catvT-gyDY9kSY7NoDy1JPy1P9Snoy8vhF4DdsK70pMF_r1UJdSIlseANKMPE8KsPkUct4xOLgyIrdUY2su22-69jxSd2vEp6V48T8m_5I8gAXBaDiwpa_Izrhah31yz_0Y22F1QO7KpTqIuwKen36d_AbvPBUT
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+of+inflammation%2C+immunity%2C+and+oxidative+stress+in+hypertension%3A+New+insights+and+potential+therapeutic+targets&rft.jtitle=Frontiers+in+immunology&rft.au=Zhang%2C+Zenglei&rft.au=Zhao%2C+Lin&rft.au=Zhou%2C+Xingyu&rft.au=Meng%2C+Xu&rft.date=2023-01-10&rft.issn=1664-3224&rft.eissn=1664-3224&rft.volume=13&rft_id=info:doi/10.3389%2Ffimmu.2022.1098725&rft.externalDBID=n%2Fa&rft.externalDocID=10_3389_fimmu_2022_1098725
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon